Bristol Myers Squibb Acquires Nvidia AI In a significant move that underscores the growing intersection of technology and pharmaceuticals, Bristol Myers Squibb (BMS) has announced its acquisition of an Nvidia DGX SuperPOD. This advanced AI system, built on Nvidia's...
Public Health AI Trials In an exciting development for the intersection of technology and public health, a new initiative has been launched involving generative AI tools. The Coalition for Health AI, alongside major players like OpenAI, Anthropic, and Accenture, is...
AI Agents: Context Layer Bottleneck Over the past two years, I have observed a recurring pattern in the development of AI agents. Teams build promising models, only to encounter reliability issues that lead them to upgrade their models repeatedly. However, the...